Thermo Fisher Scientific Inc. (TMO) Position Decreased by Charter Trust Co.

Charter Trust Co. cut its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 1.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 17,993 shares of the medical research company’s stock after selling 239 shares during the quarter. Charter Trust Co.’s holdings in Thermo Fisher Scientific were worth $3,416,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of TMO. Beach Investment Management LLC. grew its holdings in Thermo Fisher Scientific by 1,702.8% in the 2nd quarter. Beach Investment Management LLC. now owns 71,661 shares of the medical research company’s stock valued at $12,503,000 after buying an additional 67,686 shares in the last quarter. Arrow Financial Corp grew its holdings in shares of Thermo Fisher Scientific by 288.0% during the 2nd quarter. Arrow Financial Corp now owns 2,328 shares of the medical research company’s stock worth $406,000 after purchasing an additional 1,728 shares in the last quarter. Canada Pension Plan Investment Board grew its holdings in shares of Thermo Fisher Scientific by 56.3% during the 2nd quarter. Canada Pension Plan Investment Board now owns 435,761 shares of the medical research company’s stock worth $76,027,000 after purchasing an additional 156,962 shares in the last quarter. Bright Rock Capital Management LLC grew its holdings in shares of Thermo Fisher Scientific by 200.0% during the 2nd quarter. Bright Rock Capital Management LLC now owns 42,000 shares of the medical research company’s stock worth $7,328,000 after purchasing an additional 28,000 shares in the last quarter. Finally, Wetherby Asset Management Inc. grew its holdings in shares of Thermo Fisher Scientific by 13.0% during the 2nd quarter. Wetherby Asset Management Inc. now owns 6,169 shares of the medical research company’s stock worth $1,076,000 after purchasing an additional 711 shares in the last quarter. 86.25% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Thermo Fisher Scientific Inc. (NYSE TMO) traded up $3.47 during mid-day trading on Wednesday, hitting $211.48. The company had a trading volume of 1,461,968 shares, compared to its average volume of 1,600,827. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc. has a twelve month low of $140.00 and a twelve month high of $211.81. The company has a market cap of $84,360.00, a P/E ratio of 35.90, a P/E/G ratio of 1.71 and a beta of 1.06.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, topping the consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a return on equity of 15.94% and a net margin of 11.73%. The business had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same period in the prior year, the company earned $2.03 EPS. Thermo Fisher Scientific’s revenue for the quarter was up 13.9% on a year-over-year basis. analysts anticipate that Thermo Fisher Scientific Inc. will post 9.36 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Monday, January 15th. Investors of record on Friday, December 15th were given a dividend of $0.15 per share. The ex-dividend date of this dividend was Thursday, December 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.28%. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

Several analysts have recently issued reports on TMO shares. Leerink Swann increased their target price on Thermo Fisher Scientific from $190.00 to $207.00 and gave the stock an “outperform” rating in a report on Monday, October 9th. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $212.00 target price on the stock in a report on Thursday, September 21st. Deutsche Bank set a $226.00 target price on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Thursday, October 26th. Barclays reissued an “overweight” rating and set a $215.00 target price (up from $200.00) on shares of Thermo Fisher Scientific in a report on Monday, September 25th. Finally, Evercore ISI started coverage on Thermo Fisher Scientific in a report on Wednesday, January 3rd. They set an “outperform” rating and a $220.00 target price on the stock. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and fifteen have issued a buy rating to the company. Thermo Fisher Scientific has a consensus rating of “Buy” and a consensus price target of $212.21.

In related news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction on Friday, December 15th. The stock was sold at an average price of $191.74, for a total transaction of $9,587,000.00. Following the completion of the sale, the chief executive officer now directly owns 302,577 shares in the company, valued at approximately $58,016,113.98. The sale was disclosed in a filing with the SEC, which is available through this link. 0.49% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION WARNING: “Thermo Fisher Scientific Inc. (TMO) Position Decreased by Charter Trust Co.” was posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.com-unik.info/2018/01/17/thermo-fisher-scientific-inc-tmo-position-decreased-by-charter-trust-co.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit